Review
Open access
Jul 2026
Engineering immunity in osteosarcoma: nanomedicine strategies for overcoming immune evasion
Multi-targeted nanomedicine delivery systems hold strong preclinical potential to provide a novel framework for advancing osteosarcoma treatment by precisely modulating the TME and eliciting durable antitumor immune responses.
Qin Huang, Gong-Chang Yu, Bin Shi et al.
· Frontiers in Immunology · 0 citations